HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neural spectrum: palisaded encapsulated neuroma and verocay body poor dermal schwannoma.

Abstract
We examined 25 palisaded encapsulated neuromas (PEN) of the skin and used peripherin antibody as an immunohistochemical label for axons. Quantitative analysis of the axon to schwann cell nuclear ratio for each PEN was determined by examining cross-sectioned neuroid fascicles. This revealed that 120 of the 253 cross-sectioned fascicles in PEN lacked axon and only 5% of the fascicles had an axon to schwann cell nuclear ratio greater than 1:2. In contrast, all fascicles in 40 dermal nerves adjacent to PENs as well as 35 traumatic neuromas in surgical scars had an axon to schwann cell nuclear ratio of at least 1:2 and the majority a ratio of 1:1 or higher. These results suggest that there is a spectrum between PENs which are axon rich to a form of schwannoma with an identical histopathology which lacks significant axonal content and that not all PENs are true neuromas.
AuthorsS Kossard, A Kumar, B Wilkinson
JournalJournal of cutaneous pathology (J Cutan Pathol) Vol. 26 Issue 1 Pg. 31-6 (Jan 1999) ISSN: 0303-6987 [Print] United States
PMID10189242 (Publication Type: Journal Article)
Chemical References
  • CD57 Antigens
  • Intermediate Filament Proteins
  • Membrane Glycoproteins
  • Nerve Tissue Proteins
  • PRPH protein, human
  • Peripherins
  • S100 Proteins
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Axons (chemistry)
  • CD57 Antigens (analysis)
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunohistochemistry
  • Intermediate Filament Proteins (analysis)
  • Male
  • Membrane Glycoproteins
  • Middle Aged
  • Nerve Sheath Neoplasms (metabolism, pathology)
  • Nerve Tissue Proteins (analysis)
  • Neurilemmoma (metabolism, pathology)
  • Neuroma (metabolism, pathology)
  • Peripherins
  • S100 Proteins (analysis)
  • Schwann Cells (chemistry)
  • Skin Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: